Hyo-Soo Kim
Overview
Explore the profile of Hyo-Soo Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
690
Citations
13179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Park S, Park E, Lee S, Ahn J, Lee Y, Joo D, et al.
Hellenic J Cardiol
. 2025 Feb;
PMID: 39971193
Objective: The impact of renal function on revascularization outcomes in patients with acute myocardial infarction and multivessel disease remains unclear. This study compared long-term outcomes of complete (CR) and incomplete...
2.
Kang S, Moon J, Lee S, Kim S, Kang J, Kim H, et al.
Circ Genom Precis Med
. 2025 Feb;
:e004998.
PMID: 39945096
No abstract available.
3.
Jo J, Lee S, Joh H, Kim H, Kim J, Hong Y, et al.
Crit Care
. 2025 Feb;
29(1):65.
PMID: 39915828
Background: Although potent P2Y inhibitors, such as ticagrelor and prasugrel, are standard treatment in patients with acute myocardial infarction (AMI), evidence for their efficacy and safety compared with clopidogrel is...
4.
Cho S, Kang J, Zhang J, Hu X, Hwang J, Kwak J, et al.
EuroIntervention
. 2025 Feb;
21(3):e183-e192.
PMID: 39901633
Background: A recent randomised trial demonstrated fractional flow reserve (FFR) guidance for percutaneous coronary intervention (PCI) was non-inferior to intravascular ultrasound (IVUS) guidance regarding clinical outcomes, with a lower frequency...
5.
Choi K, Nam C, Bruno F, Cho Y, De Luca L, Kang J, et al.
J Am Heart Assoc
. 2025 Feb;
14(3):e037657.
PMID: 39895551
Background: Although true bifurcation lesions are associated with a high risk of procedural complications, the differential prognostic implications of percutaneous coronary intervention for true bifurcations according to lesion location are...
6.
Yap J, Hayashida K, Lee M, Stub D, Hon J, Ho K, et al.
JACC Asia
. 2025 Jan;
4(12):885-897.
PMID: 39802986
Transcatheter aortic valve implantation (TAVI) has been established as an effective treatment modality in patients with severe aortic stenosis (AS) and the uptake of TAVI is rapidly growing in the...
7.
Kim S, Kim H, Park J, Choi K, Nam J, Lee C, et al.
J Yeungnam Med Sci
. 2024 Dec;
42:18.
PMID: 39716364
Background: Complete revascularization has demonstrated better outcomes in patients with acute myocardial infarction (AMI) and multivessel disease. However, in the case of left main (LM) culprit lesion AMI with multivessel...
8.
Jang J, Ga-In Y, Jongwha A, Bae J, Yun-Ho C, Kang M, et al.
Thromb Haemost
. 2024 Dec;
PMID: 39657950
Aim To assess an optimal long-term antiplatelet strategy in patients at both high ischaemic and bleeding risks after percutaneous coronary intervention (PCI). Methods and results Patients both at high ischaemic...
9.
Jeong J, Park J, Kim B, Kim H, Choi K, Nam J, et al.
Front Cardiovasc Med
. 2024 Dec;
11:1447952.
PMID: 39639979
Background: Data on the clinical impact of beta-blockers (BBs) in patients with myocardial infarction (MI) who had non-reduced left ventricular ejection fraction (LVEF) after percutaneous coronary intervention are limited. Methods:...
10.
Kang J, Chung J, Park K, Bae J, Lee H, Hwang D, et al.
JAMA Cardiol
. 2024 Nov;
PMID: 39602157
Importance: Antiplatelet monotherapy in the chronic maintenance period for patients with high bleeding risk (HBR) and those who have undergone complex percutaneous coronary intervention (PCI) has not yet been explored....